In vitro effect of a non-immunosuppressive FKBP ligand, FK1706, on SARS-CoV-2 replication in combination with antivirals
W. Fitzsimmons, T. L. Hartman, M. Mendenhall, C. Chen
The paper evaluates FK1706, a non-immunosuppressive FKBP ligand, in vitro against SARS-CoV-2 alone and in combination with remdesivir, showing synergistic activity.
bioRxiv · Feb 3, 2022 · PreprintPharmacology & Toxicology